1. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007; 8:326–331. PMID:
17610454.
Article
2. Maihöfner C, Seifert F, Markovic K. Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol. 2010; 17:649–660. PMID:
20180838.
Article
3. Bhattarai B, Shrestha BP, Rahman TR, Sharma SK, Tripathi M. Complex regional pain syndrome (CRPS) type-1 following snake bite: a case report. Nepal Med Coll J. 2008; 10:278–280. PMID:
19558072.
4. Ergan SA, Yoleri Ö, Yavaşi S, Ölmez N, Memiş A. Complex regional pain syndrome caused by snake bite: a case report. Turk J Phys Med Rehabil. 2012; 58:69–71.
5. de Mos M, Sturkenboom MC, Huygen FJ. Current understandings on complex regional pain syndrome. Pain Pract. 2009; 9:86–99. PMID:
19215592.
Article
6. Goebel A. Current concepts in adult CRPS. Br J Pain. 2011; 5:3–11.
Article
7. Del Brutto OH, Del Brutto VJ. Neurological complications of venomous snake bites: a review. Acta Neurol Scand. 2012; 125:363–372. PMID:
21999367.
Article
8. Chacur M, Gutiérrez JM, Milligan ED, Wieseler-Frank J, Britto LR, Maier SF, et al. Snake venom components enhance pain upon subcutaneous injection: an initial examination of spinal cord mediators. Pain. 2004; 111:65–76. PMID:
15327810.
Article
9. Chacur M, Milligan ED, Sloan EM, Wieseler-Frank J, Barrientos RM, Martin D, et al. Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide. Pain. 2004; 108:180–191. PMID:
15109522.
Article
10. Chacur M, Longo I, Picolo G, Gutiérrez JM, Lomonte B, Guerra JL, et al. Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon. 2003; 41:667–678. PMID:
12727271.
Article
11. Seong WK, Chung KT, Kim HH, Park JG, Park YM, Oh HB. Immunological characterization of the venoms from Korean snakes of the genus Agkistrodon (2). Rep Natl Ins Health. 1998; 35:32–33.
12. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain. 2006; 22:235–239. PMID:
16514322.
Article
13. Otero R, Gutiérrez J, Beatriz Mesa M, Duque E, Rodríguez O, Luis Arango J, et al. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon. 2002; 40:1107–1114. PMID:
12165312.
Article
14. Subedi A, Bhattarai B, Biswas BK, Khatiwada S. Complex regional pain syndrome (CRPS type-1) in an adolescent following extravasation of dextrose containing fluid-an underdiagnosed case. Korean J Pain. 2011; 24:112–114. PMID:
21716610.
Article
15. Coderre TJ, Bennett GJ. A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med. 2010; 11:1224–1238. PMID:
20704671.
Article
16. Lake AP. Intravenous regional sympathetic block: past, present and future? Pain Res Manag. 2004; 9:35–37. PMID:
15007401.
Article
17. Tran de QH, Duong S, Bertini P, Finlayson RJ. Treatment of complex regional pain syndrome: a review of the evidence. Can J Anaesth. 2010; 57:149–166. PMID:
20054678.
Article
18. Vanos DN, Ramamurthy S, Hoffman J. Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth Analg. 1992; 74:139–141. PMID:
1734775.
19. Uphouse LA, Welch SP, Ward CR, Ellis EF, Embrey JP. Antinociceptive activity of intrathecal ketorolac is blocked by the kappa-opioid receptor antagonist, nor-binaltorphimine. Eur J Pharmacol. 1993; 242:53–58. PMID:
8223936.
Article